Transgenic FAR expression significantly decreases fly survival and increases bacterial load 24-hours post-injection. by Sophia C. Parks (11624976)

Osr1 heterozygous mice experienced decreased bile acid synthesis in the liver. by Ernest C. Lynch (12769954)

“…(D) Osr1 heterozygous male mice had significantly decreased expression of <i>Cyp7a1</i>, <i>Cyp27a1</i>, <i>Ehhadh</i>, <i>Cyp4a10</i> and <i>Cyp4a14</i> compared to WT male mice. …”

The mRNA expression of selected genes in cartilage cells after siRNA treatment were significantly decreased. by Fei Ye (339913)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Plot of mean compassion satisfaction by group and time. by Kunal Desai (18784208)

Subjects:

Effects of GJE extract treatment decreased accumulation of Col1a1. by Natnicha Suttawong (22367172)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

Subjects:

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Subjects:

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

Mean and standard deviations for each benthic category and for each survey year. by Matthew S. Mills (3957410)

Intention to treat (ITT) means (standard deviations) for outcome and process measures for all participants in the ACT (n = 52) and waitlist control (n = 46) groups. by Arianna Prudenzi (12436789)

Subjects:

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…The orange color indicates increase in levels and the blue color represent decrease in levels. (A) MMS status, yes vs. no (B) change in (Δ) QMG (> 40% vs. < 0%) (C) change in (Δ) MG-ADL (> 40% vs. < 0%), (D) Responder versus Non-Responder. …”

Heat map and k-means clustering of proteins (384) for which any Vpu-mutant was significantly different from wild type. by Charlotte A. Stoneham (10819125)

Relationship between the change in by Akihiro Kakimoto (343218)

Subjects:

Plot of mean secondary trauma stress by group and time. by Kunal Desai (18784208)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects: